Kidney Neoplasms Clinical Trials

10 recruiting

Kidney Neoplasms Trials at a Glance

10 actively recruiting trials for kidney neoplasms are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Nanjing, Bruges, and Cambridge. Lead sponsors running kidney neoplasms studies include Jinling Hospital, China, RenJi Hospital, and National Cancer Institute (NCI).

Browse kidney neoplasms trials by phase

Treatments under study

About Kidney Neoplasms Clinical Trials

Looking for clinical trials for Kidney Neoplasms? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Kidney CancerKidney NeoplasmsPneumothorax+1 more
National Cancer Institute (NCI)950 enrolled1 locationNCT00033137
Recruiting
Phase 2

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

Breast CancerKidney NeoplasmsLiver Neoplasms
UNC Lineberger Comprehensive Cancer Center40 enrolled1 locationNCT07225114
Recruiting
Phase 2

CD70-targeted immunoPET Imaging of Kidney Cancer

NeoplasmsKidney NeoplasmsUrogenital Neoplasms+1 more
RenJi Hospital300 enrolled1 locationNCT06680089
Recruiting

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

CarcinomaCarcinoma, Renal CellNeoplasms+10 more
Jinling Hospital, China39 enrolled1 locationNCT06676527
Recruiting

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

Renal Cell CarcinomaCarcinomaKidney Cancer+2 more
Jinling Hospital, China450 enrolled1 locationNCT05917106
Recruiting

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

ParagangliomaPheochromocytomaKidney Neoplasms+5 more
The University of Texas Health Science Center at San Antonio2,000 enrolled1 locationNCT03160274
Recruiting
Phase 1Phase 2

HTL0039732 in Participants With Advanced Solid Tumours

SarcomaUrinary Bladder NeoplasmsUterine Cervical Neoplasms+11 more
Cancer Research UK150 enrolled5 locationsNCT05944237
Recruiting
Not Applicable

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

Renal Cell CarcinomaKidney CancerKidney Neoplasms+3 more
University Hospital, Ghent235 enrolled5 locationsNCT06536439
Recruiting
Not Applicable

Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage

Kidney Neoplasms
RenJi Hospital80 enrolled1 locationNCT06715878
Recruiting
Not Applicable

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

Kidney Neoplasms
Urological Research Network, LLC150 enrolled1 locationNCT05218811